nse,bse,nseindia,nse india,share price,stock price,stock value,shares prices,share prices,stock quote,stock prices, share prices, corporate announcements,board meetings,corporate actions,dividends,agm,stock split,bonus

Aarti Drugs Limited (NSE India Code : AARTIDRUGS) SELL

Company Name :

Enter Company Name or NSE Code

AARTIDRUGS Technical Levels

Resistance 2		161.92
Resistance 1		158.23
PIVOT		155.97
Support 1		152.28
Support 2		146.33

AARTIDRUGS Fundamentals

Earning Growth		-4.83%
Profit Margin		3.65
PE		6.96
EPS		17.21
Quarter		30-Sep-11

AARTIDRUGS Futures

Close
Contracts Traded
Open Interest(OI)
Change in OI
Lot Size

AARTIDRUGS Options

Most Active Call
Most Active Put
Highest OI Call
Highest OI Put
Expiry Date

AARTIDRUGS Technical Levels

Other Stocks from Pharmaceuticals Sector AARTIDRUGS ABBOTINDIA AJANTPHARM ALCHEM ALKALI ALPA AMRUTANJAN ANKURDRUGS ARL ASTRAZEN AUROPHARMA AVENTIS BALPHARMA BIOCON BLISSGVS CADILAHC CELESTIAL CIPLA DISHMAN DIVISLAB DRREDDY ELDERPHARM FDC FKONCO GLAXO GLENMARK GRANULES INDOCO INDSWFTLAB INDSWFTLTD IPCALAB JAGSNPHARM JBCHEPHARM JUBILANT KILITCH KOPRAN LUPIN LYKALABS MANGALAM MERCK MOREPENLAB NATCOPHARM NECLIFE NEULANDLAB OPTOCIRCUI ORCHIDCHEM PANACEABIO PARABDRUGS PFIZER PIRHEALTH

Sponsored Advertisement

AARTIDRUGS Share Price on 5-10-2012

Open		154
High		154.2
Low		149
Close		152.1
Volume		15324
Change		-2.05 (-1.33%)

Series		EQ
Date of Listing		19-Sep-03
Paid Up Value		10
Face Value		10
Market Capital		0 Crores
52 Week High/Low		170.4 / 72.5

Sponsored Advertisement

Aarti Drugs Limited Company Profile

Aarti Drugs (AARTIDR), a pharmaceutical company, manufactures and sells bulk drugs and specialty chemicals worldwide. Part of the USD 265 million Aarti group, the company was incorporated on Sept. 28, 1984 as a private limited company and went public on July 1, 1992. Chandrakant V. Gogri is the chairman, and the managing director is Prakash M. Patil. The company focuses on the anti-diarrhea, anti-inflammatory therapeutic groups. With eight manufacturing facilities in Tarapur and Sarigam, the company manufactures vitamins, anti-arthritis, anti-fungal, antibiotics, ACE inhibitors, anti-diabetic, anti-cholinergic, sedatives and anti-depressant drugs. It has products like Aceclofenac, Metronidazole, Ketoconazole, Ciprofloxacin HCl and Metformin HCl to name a few. The company has already commissioned and made operational its new multipurpose manufacturing facility strictly designed and built in accordance with USFDA requirements. The manufacturing-units of ADL are GMP certified. The Company is also in the process of acquiring an ISO 9002 compliance for all units with one already approved. ADL has developed a state-of-the-art R&D center in Turbhe, Mumbai. It also have two inbuilt supporting R&D centers within the manufacturing sites which all are well recognized by Department of Science and Industrial Research, Government of India. Suyash Laboratories is a subsidiary of the company. The company has a joint venture Huanggang Yinhe Aarti Pharmaceutical Company to sell its drug ingredients in China. The company is engaged in contract manufacturing and has developed anti-fouling agents. The company exports to more than 85 countries with clients like Sanofi?Aventis, Merck, ..etc. The registered office is at Plot No. N-198, MIDC, Tarapur, Pamtembhi village, Palghar taluka, Thane-401506, Maharashtra and corporate office at Mahendra Industrial Estate, Ground floor, Road No. 29, Plot No. 109-D, Sion (East), Mumbai-400022. Financials The company disclosed fall of 23.45% in standalone net profit on y-o-y basis to Rs 51.90 million, while total income dropped 9.62% y-o-y basis to Rs 1.08 billion for the quarter ended September 2010.

AARTIDRUGS Intraday Realtime Chart

AARTIDRUGS Corporate Announcements

DATE	PURPOSE
31-Jul-12	Disclosure under SEBI Takeover Regulations
26-Jul-12	Appointment of Chief Financial Officer
23-Jul-12	Disclosure under Insider Trading Regulation
09-Jul-12	Updates
08-Jun-12	Disclosure under SEBI Takeover Regulations

AARTIDRUGS Corporate Actions

DATE	PURPOSE
17-Aug-12	Annual General Meeting/ Dividend Rs.3 Per Share
17-Aug-12	AGM/DIV RS.3 PER SHARE
06-Feb-12	Interim Dividend Rs.2/- Per Share (Purpose Revised)
06-Feb-12	INTERIM DIVIDEND
06-Feb-12	INT DIV-RS.2/- PER SHARE

AARTIDRUGS Board Meetings

MEETING DATE	PURPOSE
10-Aug-12	Audited Financial Results
09-Jul-12	Results/Others
25-May-12	Results/Dividend
09-Feb-12	Miscelleneous
01-Feb-12	Results/Dividend

AARTIDRUGS Related companies

Symbol	Company Name
AARTIDRUGS	Aarti Drugs Limited
ABBOTINDIA	Abbott India Limited
AJANTPHARM	Ajanta Pharma Limited
ALCHEM	Alchemist Limited
ALKALI	Alkali Metals Limited

Most Active NSE INDIA Stocks

HDFC LITL IVRCLINFRA HDIL UNITECH JPASSOCIAT GVKPIL TATAMOTORS IFCI IBREALEST ESSAROIL GMRINFRA BIRLAPOWER HINDALCO BHEL RENUKA RCOM DLF SUZLON RELCAPITAL IDFC ADANIENT ITC TATAPOWER BALLARPUR

Free Stock Market Tips:

What does price discovery through book building process mean?

Home	Stock Market	IPO	Mutual Funds	Education	Paid Service
About us	Share Market	IPO Watch	MF News	IPO	Subscription
VJonDalalStreet	Technical Analysis	New IPO Review	Old Funds	Articles	Equity Performance
DalalStreet Blog	Stock Market News	Indian IPO News	New Funds	Stock Market	Futures Performance
Free Sms Alerts	World Stock Market	IPO Allotment Status	Best Funds	Financial Terms	Options Performance
Privacy	Stock Recommendations	Grey Market Premium	MF Analysis	Futures & Options	Jackpot Performance

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither VJonDalalStreet.com website nor any of its promoters shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes acceptance of our Disclaimer